speb/financial-data huggingface dataset:
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 26000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -31000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Payables: 1843000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3265000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Pretax Income: 337000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -24000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -80000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Receivables: 3327000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2327000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 266000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -179000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Research And Development: 402000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 3034000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 11000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 2000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1084000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1239000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Share Issued: 962920132.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 9000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -179000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 32000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 10379000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1696000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Tax Provision: 95000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 73000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -35000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Assets: 26379000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 17561000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Debt: 8426000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 10408000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Total Expenses: 3937000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 15971000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 17316000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 8770000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 400000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 58000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 110000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 12345653.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 329000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Unrealized Gain Loss: -112000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Working Capital: 1862000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1581000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — +Total Revenue: 4302000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1713000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3271000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7168000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 112000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1822000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -158000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -135000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 193000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1912000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1912000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -33000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -68000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -158000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 327000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Cash Flow From Discontinued Operation: 0.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -80000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Inventory: -102000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 12000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -66000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Payable: -80000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -80000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -240000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 101000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Common Stock: 193000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10552000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 7000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2392000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1440000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Assets: 9278000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1148000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1148000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1522000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1522000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 7030000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 691000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 87000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Deferred Tax: 87000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Depreciation: 303000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 303000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 303000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 184000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 2000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — EBIT: 353000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — EBITDA: 656000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 2000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -1000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -11000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — End Cash Position: 1912000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -68000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 382000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 169000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 296000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 154000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Goodwill: 9341000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 11920000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Gross Profit: 1911000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 80000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 182000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Interest Expense: 78000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 78000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Interest Income: 21000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 21000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Interest Paid Cfo: -63000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 17000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Inventory: 3260000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 18937000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -158000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 619000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 765000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 146000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 7000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 22000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 7237000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 7237000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 22000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 146000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 956000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 31000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Minority Interests: -3000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 3000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 7000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Net Debt: 6473000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income: 184000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 184000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 188000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -1000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 184000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 185000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 188000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 187000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -23000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Interest Income: -57000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -6000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -42000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 22000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -57000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2219000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 3000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -64000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1368000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 213000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1798000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 492000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 415000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1798000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 77000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 656000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Normalized Income: 185000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 327000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Operating Income: 330000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Operating Revenue: 4302000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 950979000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 593000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1148000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 334000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 30000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -1000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Other Gand A: 154000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Other Income Expense: 2000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2579000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 46000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 146000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 41000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -11000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Payables: 1895000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3335000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Pretax Income: 275000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -23000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -9000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Receivables: 3321000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2392000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 303000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -64000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Research And Development: 414000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3208000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Sale Of Business: 3000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 3000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1024000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1178000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Share Issued: 950979000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -64000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 32000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10552000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1368000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Tax Provision: 87000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.32
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 50000000.00
INPHI.AS cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -43000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Assets: 26339000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17789000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Debt: 8385000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10583000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Total Expenses: 3973000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 15756000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 17061000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 8726000000.00
INPHI.AS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 330000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 182000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 312000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Unrealized Gain Loss: -116000000.00
INPHI.AS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2248000000.00
INPHI.AS income_statement (annual, 2025-12-31) — +Operating Expense: 6609000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1723000000.00
INPHI.AS income_statement (annual, 2025-12-31) — +Total Revenue: 17834000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — +Total Revenue: 5098000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Accounts Payable: 1927000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1927000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3339000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3339000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3705000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3705000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7212000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7212000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -193000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -193000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 522000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 522000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 67000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 67000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 324000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 324000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Basic Average Shares: 948239000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 951164000.00
INPHI.AS income_statement (annual, 2025-12-31) — Basic EPS: 0.94
INPHI.AS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.42
INPHI.AS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2401000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1912000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Capital Expenditure: -668000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -192000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -532000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -148000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 964000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 964000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Capital Stock: 193000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 193000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2794000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2794000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2794000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2794000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -328000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Cash Equivalents: 2086000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 2086000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Cash Financial: 708000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Cash Financial: 708000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 107000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -322000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -736000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -196000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1170000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1391000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Cash Flow From Discontinued Operation: -10000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Cash Flow From Discontinued Operation: 0.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Account Payable: 97000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 360000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Inventory: -115000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Inventory: 355000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 54000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 50000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1215000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -9000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Payable: 97000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Payable: 360000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 97000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 360000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Receivables: -53000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -175000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Change In Working Capital: -1232000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 581000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -9000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Changes In Cash: 532000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 872000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Common Stock: 193000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Common Stock: 193000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -328000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 10957000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10957000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 13000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 5000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Construction In Progress: 274000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 274000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Cost Of Revenue: 9776000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2810000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1737000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1737000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Assets: 9932000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Assets: 9932000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 207000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 207000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Debt: 793000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Debt: 793000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1000000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1000000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1490000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1490000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1490000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1490000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Liabilities: 7511000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 7511000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Current Provisions: 712000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Current Provisions: 712000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Deferred Income Tax: 282000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 74000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Deferred Tax: 282000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 74000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Depreciation: 602000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Depreciation: -244000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1124000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 278000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1124000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 278000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 123000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 123000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Diluted Average Shares: 962503000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 965914000.00
INPHI.AS income_statement (annual, 2025-12-31) — Diluted EPS: 0.94
INPHI.AS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.42
INPHI.AS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 895000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 395000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 13000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 0.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 19000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 19000000.00
INPHI.AS income_statement (annual, 2025-12-31) — EBIT: 1476000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — EBIT: 522000000.00
INPHI.AS income_statement (annual, 2025-12-31) — EBITDA: 2600000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — EBITDA: 800000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -9000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -3000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 9000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 2000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -139000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 10000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — End Cash Position: 2794000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — End Cash Position: 2794000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 380000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 380000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 107000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -322000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Finished Goods: 1287000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1287000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 347000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 347000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Free Cash Flow: 504000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1199000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Gain On Sale Of Business: -25000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 1000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -17000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 291000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 291000000.00
INPHI.AS income_statement (annual, 2025-12-31) — General And Administrative Expense: 628000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 158000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Goodwill: 9271000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Goodwill: 9271000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 11840000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 11840000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 3532000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3532000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Gross PPE: 5923000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 5923000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Gross Profit: 8058000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Gross Profit: 2288000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 81000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 81000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Income Tax Payable: 174000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 174000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Interest Expense: 294000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Interest Expense: 56000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 294000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 56000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Interest Income: 83000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Interest Income: 8000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 83000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 8000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -253000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -40000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Interest Payable: 95000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Interest Payable: 95000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Interest Received Cfo: 83000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 23000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Inventory: 2870000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Inventory: 2870000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Invested Capital: 17804000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 17804000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -737000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -196000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 704000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 704000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Investments And Advances: 852000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 852000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 148000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 148000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 13000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 5000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1057000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 10000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Land And Improvements: 1105000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1105000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Leases: 1328000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Leases: 1328000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Line Of Credit: 52000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 52000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 757000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 757000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Long Term Debt: 6054000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 6054000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6811000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6811000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1057000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 16000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -609000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 148000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 148000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Long Term Provisions: 915000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 915000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1550000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1550000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Minority Interest: 32000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Minority Interest: 32000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Minority Interests: -1000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Minority Interests: -2000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -25000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -18000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 13000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 5000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Net Debt: 4053000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Net Debt: 4053000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income: 895000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income: 395000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 895000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 395000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 901000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 393000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -4000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 4000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 895000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 395000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 899000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 391000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 901000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 394000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 897000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 398000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -136000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -44000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Interest Income: -216000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Interest Income: -53000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -52000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 12000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 424000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -327000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 448000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -593000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -216000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -53000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Net PPE: 2218000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Net PPE: 2218000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 9000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 2000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -24000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 266000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -883000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -883000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 210000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 210000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1773000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1773000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 551000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 551000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 458000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 458000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1773000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1773000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 93000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 93000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Normalized EBITDA: 2641000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 800000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Normalized Income: 930324000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Normalized Income: 391000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1172000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1391000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Operating Gains Losses: 32000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 27000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Operating Income: 1449000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Operating Income: 565000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Operating Revenue: 17461000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4725000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 951288934.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 951288934.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Current Assets: -5000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: -5000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 741000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 741000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 321000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 321000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -56000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -56000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Equity Interest: -16000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -16000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Other Gand A: 628000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Other Gand A: 158000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Other Income Expense: -50000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Other Income Expense: -44000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2569000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2569000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 294000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 73000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 119000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 119000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 44000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 44000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Other Operating Expenses: -61000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -9000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Payable: 17000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Payable: 17000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Properties: 1666000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Properties: 1666000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Other Receivables: 527000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 527000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Payables: 2251000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Payables: 2251000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3988000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3988000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 180000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 180000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Pretax Income: 1182000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Pretax Income: 466000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Properties: 0.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
INPHI.AS cash_flow (annual, 2025-12-31) — Purchase Of Business: -25000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -16000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -136000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -44000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -113000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -7000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Raw Materials: 1175000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1175000000.00
INPHI.AS balance_sheet (annual, 2025-12-31) — Receivables: 3945000000.00
INPHI.AS balance_sheet (quarterly, 2025-12-31) — Receivables: 3945000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 9776000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2810000000.00
INPHI.AS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1124000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 278000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -609000000.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -313000000.00
INPHI.AS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
INPHI.AS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
INPHI.AS income_statement (annual, 2025-12-31) — Research And Development: 1700000000.00
INPHI.AS income_statement (quarterly, 2025-12-31) — Research And Development: 427000000.00